Tata Consumer Q2FY27: consolidated PAT +16% YoY to ₹470 Cr, margins expand
PAT +15.65% YoY · revenue +14% · margins expanding · beat vs street
₹5,661.13 Cr
+14% YoY
₹470.14 Cr
+15.65% YoY
8.25%
+0.1pp YoY
₹4.75
Tata Consumer's consolidated revenue for the quarter ended September 30, 2026 came in at ₹5,661 Cr, up 14% YoY (11% in constant currency, per the company's own note) and 5.8% QoQ from ₹5,349 Cr. Consolidated (Group) PAT rose 16% YoY to ₹470 Cr from ₹406.5 Cr, and 10% QoQ from ₹427.2 Cr; basic EPS was ₹4.75 versus ₹4.09 a year ago. The quarter carried a small ₹7.37 Cr exceptional (adjustment to contingent consideration on an acquisition) against none a year ago — stripping it out, adjusted consolidated PAT growth is ~17.5% YoY versus the 15.7% reported. Standalone tells a different story: standalone PAT fell 14.9% YoY to ₹242.8 Cr from ₹285.2 Cr, dragged by a much larger ₹64.37 Cr exceptional (a ₹57 Cr fair-value loss on a financial instrument held in an Associate plus the same ₹7 Cr contingent-consideration item) — a >3% divergence from the consolidated growth story that readers should know, since the Associate is equity-accounted at the Group level and the fair-value hit doesn't flow through consolidated PAT the same way.
Q2 FY-2027 vs prior quarters
Profit before exceptional items and tax rose 21% YoY to ₹632 Cr, which the company attributes directly to "higher operating profits." Our own EBITDA-style estimate (PBT-before-exceptional + finance cost + D&A − other income) works out to roughly 13.8% of revenue, up from about 13.5% both QoQ and YoY — margin expansion, consistent in direction with management's standing FY27 guidance of 50-75 bps full-year EBITDA margin expansion, though the quarter's level still sits below the ~15.0-15.5% band our pre-result preview had flagged as the Street's expectation — so this is a margin beat on trend, not yet a beat on absolute level. Growth was led by the India Branded Business, up 17% YoY to ₹3,666 Cr per the filing's own note, while International Business revenue was "marginally lower, impacted by continued heatwave"; the group continues to navigate 7-10% tea cost inflation via the calibrated pricing management flagged on the prior concall.
The stock went into the print at ₹936.5, down 5.8% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
Reaffirm double-digit revenue growth and 50-75 bps EBITDA margin expansion for FY27. Growth businesses targeting 30% normalized growth. India food business medium-term margin aspiration 17-20%. Will take calibrated pricing to protect margins amid 7-10% tea inflation and dynamic commodity costs.
— This quarter: met
Against our pre-result preview, the ₹5,661 Cr consolidated print beat the ~₹5,400-5,500 Cr revenue range flagged pre-result, and EPS growth of 16% YoY sits within the "mid-to-high teens" band the preview expected — but margin, as above, lands short of the 15.0-15.5% EBITDA band the Street was debating. Separately, FY27 full-year consensus (per market data pulled this quarter) pegs revenue near ₹22,620 Cr (+11.5%) and EPS near ₹19.56 (+24%); this quarter's 14% revenue growth and mid-teens PAT/EPS growth track that glide path without over- or under-shooting it. On corporate developments: the additional 5% stake acquired in Capital Foods (September 1, 2026) deepens the group's hold on its growth portfolio, though this filing doesn't break out "growth businesses" revenue separately so the 25-30% growth-portfolio target from the prior concall can't be directly verified here; an Income Tax Tribunal win on intangibles (October 8, 2026) is a favourable post-quarter legal development not reflected as a P&L credit in these numbers; and the September 22 trading-window closure preceded today's results as standard practice ahead of the board meeting.
W1
FY27 EBITDA margin trajectory vs the guided 50-75 bps full-year expansion — Q2 ran ~13.8% (est.), still below the Street's 15.0-15.5% pre-result band
W2
India Branded Business growth (17% YoY this quarter) holding up against 7-10% tea cost inflation as calibrated pricing continues
W3
Capital Foods integration contribution following the additional 5% stake buy (Sep 1, 2026) — not separately broken out in this filing
Margin Expansion & Growth Momentum at Inflection
Street looks for sustained revenue growth and EBITDA expansion as Capital Foods integration gains pace and tea costs ease. The real question: can the growth portfolio (25–30% target) drive earnings leverage without stumbling on margins?
The Setup: Two Stories Converging
Revenue growth is the first test. Q1 FY27 came in at ₹5,349 Cr, up 12% year-on-year and tracking ahead of the Street's ~10% FY27 growth forecast. Q2 will tell us whether this momentum is structural—fueled by the growth portfolio (Capital Foods, Organic India, et al. now contributing a material base) or a seasonal beat. The second story is margin. Management has guided for sustained EBITDA expansion. Tea costs, which spiked last year, are normalising; Capital Foods integration is boosting the portfolio mix into higher-margin zones; and the core Indian branded business remains disciplined. If Q2 delivers on both, earnings leverage kicks in and the Street's 18% earnings CAGR (FY26–29) looks credible.
~₹5,400–5,500 Cr
In line with Q1 pace (+12% YoY); FY27 Street target ~10% growth implies Q2 mid-to-low double-digit range
~15.0–15.5%
Expansion from mix, tea cost tailwinds, and Capital Foods contribution; medium-term target 17%
Mid-to-high teens %
Street forecasts 18% earnings CAGR (FY26–29); Q2 will show if margins + growth compound leverage
25–30% growth target
Capital Foods (80% stake as of Sep), Organic India, and others; a material contributor now, not a rounding error
What Strong vs Weak Looks Like
A strong Q2: Revenue in the ₹5,450–5,550 Cr range (sustaining +11–13% YoY growth), EBITDA margin ≥15.3% (showing that tea easing and Capital Foods integration are real), growth segment volume acceleration evident in call commentary, and management reaffirming FY27 double-digit growth. EPS beat of 5–10% vs Street consensus would signal pricing power and cost discipline intact. A weak Q2: Revenue below ₹5,350 Cr (growth slipping toward high single digits), EBITDA margin <14.8% (suggesting input pressures or mix headwinds not yet priced), growth portfolio stumbling on volume or pricing, and any wavering on full-year guidance. Tea volume growth showing softness (management guided mid-single-digit) or international business not gaining traction as expected would also be a concern.
On Track to Full-Year Guidance?
The company has not issued explicit Q2 or H1 FY27 guidance, but Street consensus pins FY27 at ~10% sales growth, ~14% EBITDA growth, and ~18% earnings growth (BoB Capital). Q1's +12% revenue puts the bar for H1 at ~11% if full-year lands at 10%, which is achievable but leaves little margin for error in H2. Management's guidance on margin expansion (tea costs easing, Capital Foods accretion, portfolio mix) remains the wild card—if Q2 shows EBITDA margin <14.8% or flat, it suggests headwinds (pricing pressure, mix setback, or input surprises) the Street is not yet pricing. The recent income tax tribunal win (favourable ruling on intangibles depreciation) is a one-time tailwind to reported earnings but does not affect operational trajectory.
Since Last Quarter: Filings & Moves
1 · Capital Foods acquisition (Sep 1, 2026)
Additional 5% stake acquired from Wildflower Private Trust, raising total holding to 80%. Part of earlier capex plan. Operationally, this deepens integration—Capital Foods now a majority-owned, consolidated business. Accretion to margins is the Street's thesis; watch for contribution in Q2 and management's commentary on synergies.
2 · Income Tax Tribunal win (Oct 8, 2026)
Favourable order on claim for tax depreciation on intangibles. A legal win, not an operational change; could reduce tax outgo in the year. One-time benefit—good, but doesn't drive recurring earnings.
3 · Trading window closure (Sep 24–result announcement)
Routine pre-result closure. No insider trading activity during Q2. Standard corporate governance; nothing to flag.
4 · Ownership: FII slight decline, DII uptick
FII stake fell 71 bps QoQ to 20.08% (from 20.79%), while DII rose 82 bps to 25.01%. Promoter stable at 33.83%. Mixed signal—FII exit could reflect valuation concerns after the run-up, but DII accumulation suggests domestic conviction on long-term growth story.
What to Watch on Result Day (Oct 26)
The headline numbers are secondary to guidance colour and margin trajectory. Management will field three questions: (1) Are we still on track for FY27 double-digit growth given pricing, input, and currency headwinds in the macro? (2) Is EBITDA margin expansion real, or a one-off gift from tea cost easing? (3) How much of Capital Foods is already embedded in Q2 financials, and what upside lies ahead? Separately, watch for any update on the growth portfolio (Organic India, Capital Foods, international coffee/spices)—if growth portfolio growth is slowing below 25%, the margin expansion story faces pressure. On the near term, stock momentum: the 24.7% decline from ATH (₹1,282.7) has left the stock oversold relative to the Bull consensus. A modest beat on margins + guidance reaffirmation could trigger a short-covering rally. Conversely, any downward guidance or margin miss could extend the weakness, especially if FII selling accelerates.
Tata Consumer enters Q2 with a simple narrative: grow revenue in the double-digit range (Q1's +12% is the template), expand EBITDA margins (tea easing, Capital Foods leverage, mix), and deliver earnings growth in the high teens. The Street is structurally bullish (BUY from 28 analysts, targets ₹1,230–₹1,500), betting on sustainable double-digit growth into FY29 and 17% corporate EBITDA margins by medium term. The recent 25% correction from ATH has priced in execution risk; a clean beat on margins + guidance reaffirmation could re-engage domestic accumulation and reduce the FII overhang.
The two things to scrutinize: (1) EBITDA margin QoQ and YoY trajectory—is the expansion story real, or are headwinds (inflation, FX, mix) masking the upside? (2) Growth segment contribution and commentary—how much of the 25–30% growth target is in the bag, and is management confident on pace? Everything else (revenue line, EPS, tax) follows if these two check out.